Table 3 Factors associated with post-surgical adverse DOR at 3 months after laparoscopic cystectomy
Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
Adverse DOR (n = 38) | Non-adverse DOR (n = 74) | P value | OR (95 % CI) | P value | |
Patient characteristics | |||||
Age (years) | 34.9 ± 5.0 (33.2–36.5) | 32.8 ± 4.8 (31.7–33.9) | 0.04 | − | − |
Gravidity (%) | 0.2 ± 0.6 (0.01–0.4) | 0.1 ± 0.9 (0.04–0.2) | 0.67 | ||
Parity (%) | 0.2 ± 0.5 (0.2–0.3) | 0.1 ± 0.3 (0.01–0.2) | 0.47 | ||
Body mass index (kg/m2) | 21.8 ± 4.6 (20.2–23.3) | 21.3 ± 5.2 (20.1–22.5) | 0.67 | ||
Laterality of cysts | |||||
Unilateral (%) | 13 (34.2) | 51 (68.9) | <0.001 | 4.7 (1.93–11.5) | 0.001 |
Bilateral (%) | 25 (65.8) | 23 (31.1) | |||
Total size of ovarian cyst (mm) | 79.9 ± 35.0 (68.4–91.4) | 69.6 ± 22.2 (64.4–74.7) | 0.06 | ||
Pre-surgical serum hormone concentrations | |||||
LH (mIU/mL) | 4.5 ± 4.0 (3.2–5.8) | 7.0 ± 10.0 (4.7–9.3) | 0.13 | ||
FSH (mIU/mL) | 6.4 ± 2.6 (5.6–7.3) | 6.5 ± 3.9 (5.6–7.4) | 0.96 | ||
Estradiol (pg/mL) | 79.4 ± 93.3 (48.7–110.1) | 68.7 ± 84.3 (49.1–88.2) | 0.54 | ||
CA125 (U/mL) | 65.5 ± 44.2 (50.9–80.0) | 70.6 ± 57.1 (57.4–83.9) | 0.63 | ||
AMH (ng/mL) | 2.8 ± 1.7 (2.2–3.4) | 4.6 ± 3.1 (3.9–5.3) | 0.001 | 0.65 (0.48–0.88) | 0.005 |
Peri-surgical findings | |||||
Re-ASRM score | 60.9 ± 32.1 (50.4–71.4) | 49.4 ± 27.5 (43.0–55.7) | 0.05 | ||
Total surgical duration (min) | 91.5 ± 40.8 (78.1–104.9) | 81.9 ± 32.0 (74.5–89.3) | 0.18 | ||
Total blood loss (mL) | 40.2 ± 46.1 (25.0–55.3) | 23.9 ± 26.8 (17.7–30.1) | 0.02 | − | − |